Sharing Hope and Resilience: A Personal MS Journey

Поділитися
Вставка
  • Опубліковано 25 кві 2024
  • Join us as we hear heartfelt stories of courage and hope from patient ambassadors living with multiple sclerosis (MS). Discover the power of patient ambassador
    stories, which provide an intimate look into their lives with MS, their experiences with OCREVUS, and the lessons they've learned along the way at OCREVUS
    patient education events.
    Connect with others in the OCREVUS community: ocrevusevents.....
    OCREVUS is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsingremitting
    disease, and active secondary progressive disease, and primary progressive MS. It is not known if OCREVUS is safe and effective in children.
    OCREVUS can cause infusion reactions that can be serious and require you to be hospitalized. OCREVUS increases your risk of getting certain infections, which
    can be serious, including upper respiratory tract infections, lower respiratory tract infections, skin infections and herpes infections. A rare brain infection called
    progressive multifocal leukoencephalopathy or PML that usually leads to death or severe disability has been reported with OCREVUS. OCREVUS may cause a
    decrease in some types of antibodies. Your healthcare provider will do blood tests to check your blood immunoglobulin levels. Additional serious side effects
    include the risk of cancers (malignancies), including breast cancer, and inflammation of the colon, or colitis.
    These are not all the possible side effects of OCREVUS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-
    1088. You may also report side effects to Genentech at (888) 835-2555.
    Read Important Safety Information at bit.ly/OCRsafety and Prescribing Information at bit.ly/OCRPI.

КОМЕНТАРІ •